271 reports of this reaction
1.6% of all TAFAMIDIS reports
#14 most reported adverse reaction
CARDIAC DISORDER is the #14 most commonly reported adverse reaction for TAFAMIDIS, manufactured by Pfizer Laboratories Div Pfizer Inc. There are 271 FDA adverse event reports linking TAFAMIDIS to CARDIAC DISORDER. This represents approximately 1.6% of all 17,433 adverse event reports for this drug.
Patients taking TAFAMIDIS who experience cardiac disorder should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
CARDIAC DISORDER is a less commonly reported adverse event for TAFAMIDIS, but still significant enough to appear in the safety profile.
In addition to cardiac disorder, the following adverse reactions have been reported for TAFAMIDIS:
The following drugs have also been linked to cardiac disorder in FDA adverse event reports:
CARDIAC DISORDER has been reported as an adverse event in 271 FDA reports for TAFAMIDIS. This does not prove causation, but indicates an association observed in post-market surveillance data.
CARDIAC DISORDER accounts for approximately 1.6% of all adverse event reports for TAFAMIDIS, making it a notable side effect.
If you experience cardiac disorder while taking TAFAMIDIS, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.